ArticleWorld journal of gastroenterology2024

Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors.

Bansi P Savaliya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.